Lenvatinib Plus Pembrolizumab Versus Standard of Care for Previously Treated Metastatic Colorectal Cancer: Final Analysis of the Randomized, Open-Label, Phase III LEAP-017 StudyAkihito Kawazoe, Reinhard Depenbusch, Hao‐Wei Teng et al.|Journal of Clinical Oncology|2024Cited by 77
Abstract B044: Fragmentomic features of cell-free DNA predict late-stage melanoma treatment benefit and survivalAaron B. Beasley, Elin S. Gray, Leslie Calapre et al.|Clinical Cancer Research|2024Cited by 0